Clinica Baviera
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmol… Read more
Clinica Baviera (CBAV) - Total Assets
Latest total assets as of September 2025: €228.01 Million EUR
Based on the latest financial reports, Clinica Baviera (CBAV) holds total assets worth €228.01 Million EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Clinica Baviera - Total Assets Trend (2005–2024)
This chart illustrates how Clinica Baviera’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Clinica Baviera - Asset Composition Analysis
Current Asset Composition (December 2024)
Clinica Baviera's total assets of €228.01 Million consist of 22.6% current assets and 77.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 4.8% |
| Accounts Receivable | €4.82 Million | 2.3% |
| Inventory | €3.28 Million | 1.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €8.73 Million | 4.1% |
| Goodwill | €28.31 Million | 13.4% |
Asset Composition Trend (2005–2024)
This chart illustrates how Clinica Baviera's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Clinica Baviera's current assets represent 22.6% of total assets in 2024, a decrease from 69.6% in 2005.
- Cash Position: Cash and equivalents constituted 4.8% of total assets in 2024, down from 58.8% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is goodwill at 13.4% of total assets.
Clinica Baviera Competitors by Total Assets
Key competitors of Clinica Baviera based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Clinica Baviera - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Clinica Baviera generates 1.24x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Clinica Baviera generates $ 18.97 in net profit.
Clinica Baviera - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.53 | 0.80 | 0.97 |
| Quick Ratio | 1.53 | 0.80 | 0.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €18.40 Million | € -10.43 Million | € -969.98K |
Clinica Baviera - Advanced Valuation Insights
This section examines the relationship between Clinica Baviera's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.80 |
| Latest Market Cap to Assets Ratio | 0.52 |
| Asset Growth Rate (YoY) | 18.6% |
| Total Assets | €211.95 Million |
| Market Capitalization | $110.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values Clinica Baviera's assets below their book value (0.52 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Clinica Baviera's assets grew by 18.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Clinica Baviera (2005–2024)
The table below shows the annual total assets of Clinica Baviera from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €211.95 Million | +18.65% |
| 2023-12-31 | €178.64 Million | +19.01% |
| 2022-12-31 | €150.10 Million | +12.18% |
| 2021-12-31 | €133.81 Million | +10.66% |
| 2020-12-31 | €120.92 Million | +19.06% |
| 2019-12-31 | €101.56 Million | +81.92% |
| 2018-12-31 | €55.83 Million | +3.40% |
| 2017-12-31 | €53.99 Million | +15.45% |
| 2016-12-31 | €46.77 Million | +0.84% |
| 2015-12-31 | €46.38 Million | -5.42% |
| 2014-12-31 | €49.04 Million | +1.57% |
| 2013-12-31 | €48.28 Million | -6.56% |
| 2012-12-31 | €51.67 Million | -10.70% |
| 2011-12-31 | €57.86 Million | +1.78% |
| 2010-12-31 | €56.84 Million | -3.25% |
| 2009-12-31 | €58.75 Million | -8.37% |
| 2008-12-31 | €64.12 Million | +41.71% |
| 2007-12-31 | €45.25 Million | +4.28% |
| 2006-12-31 | €43.39 Million | +44.10% |
| 2005-12-31 | €30.11 Million | -- |